142 related articles for article (PubMed ID: 28246407)
21. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
22. Zeb1-Hdac2-eNOS circuitry identifies early cardiovascular precursors in naive mouse embryonic stem cells.
Cencioni C; Spallotta F; Savoia M; Kuenne C; Guenther S; Re A; Wingert S; Rehage M; Sürün D; Siragusa M; Smith JG; Schnütgen F; von Melchner H; Rieger MA; Martelli F; Riccio A; Fleming I; Braun T; Zeiher AM; Farsetti A; Gaetano C
Nat Commun; 2018 Mar; 9(1):1281. PubMed ID: 29599503
[TBL] [Abstract][Full Text] [Related]
23. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.
Eggers JC; Martino V; Reinbold R; Schäfer SD; Kiesel L; Starzinski-Powitz A; Schüring AN; Kemper B; Greve B; Götte M
Reprod Biomed Online; 2016 Apr; 32(4):434-45. PubMed ID: 26854065
[TBL] [Abstract][Full Text] [Related]
24. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
[TBL] [Abstract][Full Text] [Related]
25. Zinc finger E-box-binding homeobox 1 (
Jiang Y; Yan L; Xia L; Lu X; Zhu W; Ding D; Du M; Zhang D; Wang H; Hu B
J Biol Chem; 2018 Dec; 293(50):19317-19329. PubMed ID: 30337365
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.
Sztukowska MN; Ojo A; Ahmed S; Carenbauer AL; Wang Q; Shumway B; Jenkinson HF; Wang H; Darling DS; Lamont RJ
Cell Microbiol; 2016 Jun; 18(6):844-58. PubMed ID: 26639759
[TBL] [Abstract][Full Text] [Related]
27. Ultraviolet A irradiation induces senescence in human dermal fibroblasts by down-regulating DNMT1 via ZEB1.
Yi Y; Xie H; Xiao X; Wang B; Du R; Liu Y; Li Z; Wang J; Sun L; Deng Z; Li J
Aging (Albany NY); 2018 Feb; 10(2):212-228. PubMed ID: 29466247
[TBL] [Abstract][Full Text] [Related]
28. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.
Barbáchano A; Fernández-Barral A; Pereira F; Segura MF; Ordóñez-Morán P; Carrillo-de Santa Pau E; González-Sancho JM; Hanniford D; Martínez N; Costales-Carrera A; Real FX; Pálmer HG; Rojas JM; Hernando E; Muñoz A
Oncogene; 2016 Jun; 35(23):2991-3003. PubMed ID: 26455323
[TBL] [Abstract][Full Text] [Related]
29. Zeb1 links epithelial-mesenchymal transition and cellular senescence.
Liu Y; El-Naggar S; Darling DS; Higashi Y; Dean DC
Development; 2008 Feb; 135(3):579-88. PubMed ID: 18192284
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
[TBL] [Abstract][Full Text] [Related]
31. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
[TBL] [Abstract][Full Text] [Related]
32. Twist predicts poor outcome of patients with astrocytic glioma.
Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
[TBL] [Abstract][Full Text] [Related]
33. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
[TBL] [Abstract][Full Text] [Related]
34. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer.
Bronsert P; Kohler I; Timme S; Kiefer S; Werner M; Schilling O; Vashist Y; Makowiec F; Brabletz T; Hopt UT; Bausch D; Kulemann B; Keck T; Wellner UF
Surgery; 2014 Jul; 156(1):97-108. PubMed ID: 24929761
[TBL] [Abstract][Full Text] [Related]
36. Effects of ZEB1 on regulating osteosarcoma cells via NF-κB/iNOS.
Xu XM; Liu W; Cao ZH; Liu MX
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1184-1190. PubMed ID: 28387915
[TBL] [Abstract][Full Text] [Related]
37. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
38. ZEB1 stimulates breast cancer growth by up-regulating hTERT expression.
Yu P; Shen X; Yang W; Zhang Y; Liu C; Huang T
Biochem Biophys Res Commun; 2018 Jan; 495(4):2505-2511. PubMed ID: 29288666
[TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of mice for conditional inactivation of Zeb1.
Brabletz S; Lasierra Losada M; Schmalhofer O; Mitschke J; Krebs A; Brabletz T; Stemmler MP
Genesis; 2017 Apr; 55(4):. PubMed ID: 28176446
[TBL] [Abstract][Full Text] [Related]
40. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
